1. Urman M, O'Sullivan RA, Nugent RA, Lentle BC. Intracranial extramedullary hematopoiesis. CT and bone marrow scan findings. Clin Nucl Med. 1991 Jun;16(6):431-4.

2. Urman M, Ammann W, Sisler J, Lentle BC, Llyod-Smith R, Loomer R, Fisher C. The role of bone scintigraphy in the evaluation of talar dome fractures. J Nucl Med. 1991 Dec;32(12):2241-4.

3. Caglar M, Naldoken S. Increased bone marrow uptake on Tc-99m DMSA scintigraphy in a patient with renal osteodystrophy. Ann Nucl Med. 1993 Nov;7(4):281-3.

4. Bakir M, Bilgic A, Ozmen M, Caglar M. The value of radionuclide splenic scanning in the evaluation of asplenia in patients with heterotaxy. Pediatr Radiol. 1994;24(1):25-8.

5. Caglar M, Moretti JL, Boissier MC. Bone scintigraphy versus human immunoglobulin scintigraphy in the clinical investigation of psoriatic arthropathy. Eur J Nucl Med. 1994 Nov;21(11):1255-7.

6. Haznedaroglu I, Tokgozoglu L, Caglar M, Kes S. Local cardiac renin-angiotensin system and hypertensive heart disease. Hypertension. 1994 Dec;24(6):816-8.

7. Moretti JL, Caglar M, Boaziz C, Caillat-Vigneron N, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med. 1995 Feb;22(2):177-80.

8. Moretti JL, Caglar M, Duran-Cordobes M, Morere JF. Can nuclear medicine predict response to chemotherapy? Eur J Nucl Med. 1995 Feb;22(2):97-100.

9. Moretti JL, Caglar M, Weinmann P. Cerebral perfusion imaging tracers for SPECT: which one to choose? J Nucl Med. 1995 Mar;36(3):359-63. Review.

10. Haznedaroglu IC, Erdem Y, Tokgozoglu L, Caglar M, Kes S, Sayinalp NM, Yorukan S. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study. Cent Afr J Med. 1995 Apr;41(4):118-23.

11. Caglar M, Tokgozoglu AM, Ercan MT, Aras T, Bekdik CF. The value of Tc-99m citrate scintigraphy in chronic osteomyelitis. An indicator of the involved bone. Clin Nucl Med. 1995 Aug;20(8):712-6.

12. Cordobes MD, Starzec A, Delmon-Moingeon L, Blanchot C, Kouyoumdjian JC, Prevost G, Caglar M, Moretti JL. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med. 1996 Feb;37(2):286-9.

13. Aygun C, Oran O, Caglar M, Tekinalp G, Yurdakok M, Yigit S. Cord blood insulin and C-peptide levels: correlations with birthweight. Acta Paediatr. 1998 Oct;87(10):1101-2.

14. Usalan C, Erdem Y, Caglar M, Altun B, Arici M, Bakkaloglu M, Yasavul U, Turgan C, Caglar S. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients. Nephrol Dial Transplant. 1998 Nov;13(11):2884-9.

15. Caglar M, Moretti JL, Buchet P, Weinmann P, Baillet G, Prigent A, Laedrich J, Le Tourmelin P, Kleinknecht D, Meyrier A. Enalapril plus frusemide MAG3 scintigraphy in hypertensive patients with atherosclerosis and moderate renal insufficiency. Nucl Med Commun. 1998 Dec;19(12):1135-40.

16. Caglar M, Adeera L. Factors affecting bone mineral density in renal transplant patients. Ann Nucl Med. 1999 Jun;13(3):141-5.

17. Caglar M, Belzberg AS, Spruston B, Sexsmith G. Time-optimized carbon-14 breath test for Helicobacter pylori contamination of the stomach. Clin Nucl Med. 1999 Sep;24(9):674-7.

18. Kiratli PO, Caglar M, Bozkurt MF. Unilateral absence of pulmonary perfusion in Swyer-James syndrome. Clin Nucl Med. 1999 Sep;24(9):706-7. No abstract available.

19. Caglar M, Ergun E, Emri S. 99Tcm-MAA lung scintigraphy in patients with Behcet's disease: its value and correlation with clinical course and other diagnostic modalities. Nucl Med Commun. 2000 Feb;21(2):171-9.

20. Ercan MT, Caglar M. Therapeutic radiopharmaceuticals. Curr Pharm Des. 2000 Jul;6(11):1085-121. Review.

21. Ergun EL, Caglar M, Erdem Y, Usalan C, Ugur O, Duranay M. Tc-99m DTPA acetylsalicylic acid (aspirin) renography in the detection of renovascular hypertension. Clin Nucl Med. 2000 Sep;25(9):682-90.

22. Caglar M, Naldoken S. Multiple brown tumors simulating bone metastases: a case of parathyroid adenoma coexisting with papillary carcinoma of the thyroid. Clin Nucl Med. 2000 Oct;25(10):772-4.

23. Caglar M, Ciftci I, Hosal S, Kilinc K, Ercan MT. Detection of head and neck cancer with 99Tc(m) glutathione: a correlative study with tissue glutathione and glutathione S-transferase levels. Nucl Med Commun. 2001 Jan;22(1):33-8.

24. Caglar M, Ceylan E. Isolated carpal bone metastases from bronchogenic cancer evident on bone scintigraphy. Clin Nucl Med. 2001 Apr;26(4):352-3.

25. Ergun EL, Caglar M. Tc-99m-DTPA captopril renography in the detection of renovascular hypertension due to renal polar artery stenosis. Ann Nucl Med. 2001 Apr;15(2):167-70.

26. Caglar M, Naldoken S. Asymmetric limb uptake on Ga-67 citrate scintigraphy. Clin Nucl Med. 2001 Aug;26(8):713.

27. Caglar M, Yaris N, Akyuz C. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity. Nucl Med Commun. 2001 Dec;22(12):1325-32.

28. Tuncel, M., Caglar M. Osteoid osteoma of the rib detected on bone scintigraphy: Importance of pattern recognition (2002) Clinical Nuclear Medicine, 27; 216-217.

29. Abali, H., Haznedaroglu, I.C., Goker, H., Celik, I., Ozatli, D., Koray, Z., Caglar M. Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences. (2002) Hematology 7; 75-82.

30. Caglar M Tuncel, M. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: Effect of hormonal therapy and poor histologic differentiation (2002) Clinical Nuclear Medicine, 27; 532-533.

31. Caglar M Sari, O., Akcan, Y. Prediction of therapy response to interferon-alpha in chronic viral hepatitis-B by liver and hepatobiliary scintigraphy (2002) Annals of Nuclear Medicine, 16 (7), Pages 511-514

32. Caglar M., Tuncel, M., Alpar, R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. (2002) Clinical Nuclear Medicine, 27; 767-771.

34. Caglar M., Ceylan, E., Ozyar, E.Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: Should bone scans be used for follow-up? (2003) Nuclear Medicine Communications, 24; 1231-1236

35. Caglar M Tuncel, M., Usubutun, A. Increased Uptake on I-131 Whole-Body Scintigraphy in Warthin Tumor Despite False-Negative Tc-99m Pertechnetate Salivary Gland Scintigraphy (2003) Clinical Nuclear Medicine, 28; 945-946.

36. Dal, D., Kanbak, M., Caglar M., Aypar, U. A background infusion of morphine does not enhance postoperative analgesia after cardiac surgery (2003) Canadian Journal of Anesthesia, 50; 476-479.

37. Caglar M Volkan, B., Alpar, R. Reliability of radionuclide gastroesophageal reflux studies using visual and time-activity curve analysis: inter-observer and intra-observer variation and description of minimum detectable reflux. (2003) Nuclear medicine communications, 24; 421-428.

38. Yildiz, F., Zengin, N., Engin, H., Güllu, I., Barista, I., Caglar M., Ozyar, E., Tekuzman, G. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease (2004) International Journal of Radiation Oncology Biology Physics, 60; 839- 846.

39. Caglar M., Tuncel, M., Alpar, R. Value of technetium scintigraphy and iodine uptake measurement during follow-up of differentiated thyroid cancer (2004) Annals of Nuclear Medicine, 479- 482

40. Altun, B., Kiykim, A.A., Seyrantepe, V., Usalan, C., Arici, M., Caglar M Erdem, Y., Caglar, S. .Association between activated renin angiotensin system and bone formation in hemodialysis patients: Is the bone mass genetically determined by ACE gene polymorphism? (2004) Renal Failure, 26; 425-431.

41. Moretti, J.-L., Hauet, N., Caglar M Rebillard, O., Burak, Z. To use MIBI or not to use MIBI? That is the question when assessing tumour cells (2005) European Journal of Nuclear Medicine and Molecular Imaging, 32; 836-842.

42. Caglar M Mahmoudian B, Aytemir K. ve ark. Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results. Nucl Med Commun. 2006 Jan;27(1):61-9.

43. Caglar M Ergun EL. Lymphatic leakage in a renal transplant: The role of lymphoscintigraphy. Clin Nucl Med. 2006 Aug;31(8):486-9.

44. Caglar M, Kıratlı P, Karabulut E. Inter- and Intraobserver Variability of 99mTc-DMSA Renal Scintigraphy: Impact of Oblique Views.J Nucl Med Technol. 2007 May 11

45. Kara A, Tezer H, Devrim I, Caglar M, Cengiz AB, Gur D, Secmeer G. Primary sternal osteomyelitis in a healthy child due to community-acquired methicillin-resistant Staphylococcus aureus and literature review. Scand J Infect Dis. 2007;39(5):469-72

46.EserLayErgün, Caglar M, MuratFaniBozkurt, HakanErgün. 99mTc sestamibi myocardial perfusion scintigraphy with the novel use of metamizol for the detection of perfusion reversibility. Eur J Nucl Med Mol Imaging 2008 Aug;35(8):1530-6

47. GK Gedik, Caglar M, S Ünal, F Gümrük, Evaluation of cardiovascular complications with 99mTc tetrofosmin gated myocardial perfusion scintigraphy in patients with thalassemia major. Rev Esp Med Nucl 2008 May;27(3):191-198.

48. Kıratli P, Tuncel M, Özkutlı D, Caglar M. Gated myocardial perfusion scintigraphy in children with myocarditis: can it be considered as an indicator of clinical outcome Nucl Med Commun 2008 Oct;29(10):907-14

49. Caglar M, Gedik GK, Karabulut E. Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical. Nucl Med Commun 2008 Nov;29(11):1002-5

50. Caglar M, Kara M, Aksoy T, Kıratli Po, Karabulut E, Dogan R. Is the predicted postoperative FEV1 estimated by planar lung perfusion scintigraphy accurate in patients undergoing pulmonary resection? Comparison of two processing methods. Ann Nucl Med 2010 Jul;24(6):447-53. Epub 2010 Apr 9.

51. Caglar M, Bozkurt FM, Akca CK, Vargol SE, Bayraktar M, Ugur O, Karaağaoğlu E.Nucl Med Commun. 2012 Mar;33(3):268-74 Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.

52. Caglar M, Yener C, Karabulut E. nt J Comput Assist Radiol Surg. 2015 Jul;10(7):993-1002.Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.

53. Caglar M, Kupik O, Karabulut E, Høilund-Carlsen PF.

Rev Esp Med Nucl Imagen Mol. 2016 Jan-Feb;35(1):3-11. doi: 10.1016/j.remn.2015.08.006. Epub 2015 Oct 26. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?